Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $15.61 and last traded at $15.32, with a volume of 574261 shares trading hands. The stock had previously closed at $15.20.
Silverback Therapeutics Price Performance
The firm has a market capitalization of $581.98 million, a P/E ratio of -6.50 and a beta of 0.60. The stock’s fifty day simple moving average is $13.95 and its 200 day simple moving average is $11.29.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
See Also
- Five stocks we like better than Silverback Therapeutics
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- Gilead’s Stock Surge: What’s Fueling the Momentum?
- ESG Stocks, What Investors Should Know
- Breakout Alert: Qualcomm Just Hit The Rally Button
- How Investors Can Find the Best Cheap Dividend Stocks
- Mercado Libre Shares Go on Sale: Is Now the Time to Buy?
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png&h=45&w=95&zc=2){kind=logo}
